These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Study of the binding between uric acid and plasma proteins (author's transl)]. Sforza GR; Marcolongo R; Della Fazia L; Masciangelo F; Morozzi G; Lo Cosmo C Quad Sclavo Diagn; 1980 Dec; 15(4):1075-89. PubMed ID: 7454962 [TBL] [Abstract][Full Text] [Related]
43. [Adaptation of the SMAC for the determination of uric acid with an uricase/perioxidase procedure (author's transl)]. Scholer A; Müller E; Toth F; Vonderschmitt DJ J Clin Chem Clin Biochem; 1978 Apr; 16(4):255-7. PubMed ID: 641455 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of a urate lowering regimen in primary gout. Bailén R; González Senac NM; López MM; Llena ML; Migoya M; Rodríguez MT; de Miguel E; Torres RJ; Puig JG Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):174-80. PubMed ID: 24940666 [TBL] [Abstract][Full Text] [Related]
46. Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Takahashi S; Yamamoto T; Moriwaki Y; Tsutsumi Z; Yamakita J; Higashino K Adv Exp Med Biol; 1998; 431():57-60. PubMed ID: 9598031 [TBL] [Abstract][Full Text] [Related]
47. Gout with normal serum urate concentration. Snaith ML; Coomes EN Br Med J; 1977 Mar; 1(6062):685-6. PubMed ID: 843870 [No Abstract] [Full Text] [Related]
48. Pegloticase (krystexxa) for treatment of refractory gout. Med Lett Drugs Ther; 2011 Feb; 53(1357):9-10. PubMed ID: 21304442 [No Abstract] [Full Text] [Related]
49. Evaluation and treatment of gout as a chronic disease. Perez-Ruiz F; Herrero-Beites AM Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464 [TBL] [Abstract][Full Text] [Related]
50. [The effect of fructose on uric acid metabolism]. Holländer E Acta Med Acad Sci Hung; 1974; 31(3-4):147-55. PubMed ID: 4469712 [No Abstract] [Full Text] [Related]
51. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study. Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450 [TBL] [Abstract][Full Text] [Related]
52. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. Cheuk DK; Chiang AK; Chan GC; Ha SY Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561 [TBL] [Abstract][Full Text] [Related]
53. [Clinical trial of urate oxidase]. Asch L Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):129-36. PubMed ID: 4563393 [No Abstract] [Full Text] [Related]
54. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT). Christensen HD; Sheta HM; Morillon MB; Hansen IM Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121 [TBL] [Abstract][Full Text] [Related]
55. [New trend in gout treatment. Clinical and biological study of urate oxidase]. Mizon JP; Plaquet R; Gentit F; Quiret JC Lille Med; 1971 Nov; 16(9):1332-45. PubMed ID: 4945000 [No Abstract] [Full Text] [Related]
56. [The uric acid-lowering effect of diflunisal]. Fasching U Wien Klin Wochenschr; 1987 Nov; 99(22):791-3. PubMed ID: 3433782 [TBL] [Abstract][Full Text] [Related]
57. An association of smoking with serum urate and gout: A health paradox. Fanning N; Merriman TR; Dalbeth N; Stamp LK Semin Arthritis Rheum; 2018 Jun; 47(6):825-842. PubMed ID: 29398126 [TBL] [Abstract][Full Text] [Related]